A population health assessment of screening mammography on breast cancer mortality in North Carolina

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD (2015) Benefits and harms of breast cancer screening: a systematic review. JAMA 314(15):1615–1634. https://doi.org/10.1001/jama.2015.13183

Article  CAS  PubMed  Google Scholar 

ACS (2021) American cancer society. cancer facts & Figures 2021. American cancer society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed 23 Jan 2022

Shapiro S, Venet W, Strax P, Venet L, Roeser R (1982) Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69(2):349–355

CAS  PubMed  Google Scholar 

Bjurstam NG, Björneld LM, Duffy SW (2016) Updated results of the gothenburg trial of mammographic screening. Cancer 122(12):1832–1835. https://doi.org/10.1002/cncr.29975

Article  PubMed  Google Scholar 

Nyström L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J (2017) Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. J Med Screen 24(1):34–42. https://doi.org/10.1177/0969141316648987

Article  PubMed  Google Scholar 

Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A (1999) 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353(9168):1903–1908. https://doi.org/10.1016/s0140-6736(98)07413-3

Article  CAS  PubMed  Google Scholar 

Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the canadian national breast screening study: randomised screening trial. BMJ 348:g366. https://doi.org/10.1136/bmj.g366

Article  PubMed  PubMed Central  Google Scholar 

CDC (2020) Breast cancer screening guidelines for women. https://www.cdc.gov/cancer/breast/pdf/breast-cancer-screening-guidelines-508.pdf. Accessed Jan 23 2022

Bevers TB, Helvie MA, Bonaccio E, Camp M, Chikarmane S, Conant EF, DiNome M, Eghtedari M, Farrar WB, Flanagan MR, Harris RE, Hodgkiss L, Hoyt TL, Jochelson MS, Khan S, Lehman CD, Lancaster RB, Mauer C, Maxwell J, Niell BL, Patel BK, Pearlman M, Philpotts L, Plecha D, Pilichata JK, Smith ML, STrige RM, Tuite C, Tumyan L, Winkler Ns (2021) NCCN Clinical practice guidelines in oncology: breast cancer screening and diagnosis. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf. Accessed 23 Jan 2022

USDHHS (2022) Healthy People 2030. https://health.gov/healthypeople. Accessed 26 Apr 2022

Ahmed AT, Welch BT, Brinjikji W, Farah WH, Henrichsen TL, Murad MH, Knudsen JM (2017) Racial disparities in screening mammography in the united states: a systematic review and meta-analysis. J Am Coll Radiol 14(2):157-165.e159. https://doi.org/10.1016/j.jacr.2016.07.034

Article  PubMed  Google Scholar 

Lipscomb J, Fleming ST, Trentham-Dietz A, Kimmick G, Wu XC, Morris CR, Zhang K, Smith RA, Anderson RT, Sabatino SA (2016) What predicts an advanced-stage diagnosis of breast cancer? Sorting out the influence of method of detection, access to care, and biologic factors. Cancer Epidemiol Biomarkers Prev 25(4):613–623. https://doi.org/10.1158/1055-9965.Epi-15-0225

Article  PubMed  PubMed Central  Google Scholar 

Bureau UC (2022) United States Decennial Census. https://data.census.gov/cedsci/table?q=United%20States&tid=DECENNIALPL2020.P1. Accessed 12 May 2022

NCCPCB (2017) Reducing the burden of cancer in North Carolina: A data and resource guide for communities to fight cancer. https://publichealth.nc.gov/chronicdiseaseandinjury/cancerpreventionandcontrol/docs/ReducingtheBurdenofCancerResourceGuide.pdf. Accessed 23 Apr 2019

Bureau USC (2022) Annual estimates of the resident population for selected age groups by sex: April 1, 2010 to July 1, 2019. https://www.census.gov/data/tables/time-series/demo/popest/2010s-state-detail.html. Accessed 24 Jan 2022

County Health Rankings & Roadmaps. buidling a culture of health, county by county. (2020) Robert Woods Johnson Foundation Program. https://www.countyhealthrankings.org/reports/state-reports/2020-north-carolina-report. Accessed 11 June 2020

HRSA (2022) Area health resource file. https://data.hrsa.gov/topics/health-workforce/ahrf. Accessed 4 Mar 2022

FDA U (2022) FDA Certified mammography facilities. https://www.fda.gov/radiation-emitting-products/consumer-information-mqsa/search-certified-facility. Accessed 4 March 2022

National health literacy mapping to inform health care policy. health literacy data map. (2022) University of North Carolina at Chapel Hill. http://healthliteracymap.unc.edu/#. Accessed 18 Apr 2022

NCI, CDC (2022) State cancer profiles: screening and risk factors Table. https://www.statecancerprofiles.cancer.gov/risk/index.php. Accessed 4 Mar 2022

Raghunathan TE, Xie D, Schenker N, Parsons VL, Davis WW, Dodd KW, Feuer EJ (2007) Combining information from two surveys to estimate county-level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 102(478):474–486. https://doi.org/10.1198/016214506000001293

Article  CAS  Google Scholar 

CDC (2022) National health interview survey. https://www.cdc.gov/nchs/nhis/index.htm. Accessed 4 Mar 2022

CDC (2019) BRFSS Statistical brief on breast cancer screening. https://www.cdc.gov/brfss/data_documentation/pdf/brfss-statistical-brief-breast-cancer-screening-questions-508.pdf. Accessed 4 Mar 2022

Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998–2005. https://doi.org/10.1056/NEJMoa1206809

Article  CAS  PubMed  Google Scholar 

The benefits and harms of breast cancer screening an independent review (2012). Lancet 380 (9855):1778–1786 https://doi.org/10.1016/s0140-6736(12)61611-0

Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447. https://doi.org/10.1056/NEJMoa1600249

Article  PubMed  Google Scholar 

Harding C, Pompei F, Burmistrov D, Wilson R (2019) Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975–2009. Int J Cancer 144(3):476–488. https://doi.org/10.1002/ijc.31904

Article  CAS  PubMed  Google Scholar 

Yaffe MJ, Seely JM, Gordon PB, Appavoo S, Kopans DB (2022) The randomized trial of mammography screening that was not-a cautionary tale. J Med Screen 29(1):7–11. https://doi.org/10.1177/09691413211059461

Article  PubMed  Google Scholar 

NIH/NCI (2022) Methodology for the model-based small area estimates of cancer risk factors and screening behaviors. https://sae.cancer.gov/nhis-brfss/methodology.html. Accessed 12 May 2022

Liu B, Parsons V, Feuer EJ, Pan Q, Town M, Raghunathan TE, Schenker N, Xie D (2019) Small area estimation of cancer risk factors and screening behaviors in us counties by combining two large national health surveys. Prev Chronic Dis 16:E119. https://doi.org/10.5888/pcd16.190013

Article  PubMed  PubMed Central  Google Scholar 

Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN. 2017 Breast Cancer Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer Journal Clinicians 67 (4):290–303 https://doi.org/10.3322/caac.21393

Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295(21):2492–2502. https://doi.org/10.1001/jama.295.21.2492

Article  CAS  PubMed  Google Scholar 

Bayard S, Fasano G, Chen Y, Davis M, Drotman M, Bensenhaver J, Swistel A, Simmons R, Marti J, Newman L (2021) Screening mammography mitigates breast cancer disparities through early detection of triple negative breast cancer. Clin Imaging 80:430–437. https://doi.org/10.1016/j.clinimag.2021.08.013

Article  PubMed  Google Scholar 

DuBenske LL, Schrager S, McDowell H, Wilke LG, Trentham-Dietz A, Burnside ES (2017) Mammography screening: gaps in patient’s and physician’s needs for shared decision-making. Breast J 23(2):210–214. https://doi.org/10.1111/tbj.12779

Article  PubMed  Google Scholar 

Schueler KM, Chu PW, Smith-Bindman R (2008) Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health 17(9):1477–1498. https://doi.org/10.1089/jwh.2007.0603

Article  Google Scholar 

Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156(7):491–499. https://doi.org/10.7326/0003-4819-156-7-201204030-00005

Article  PubMed  Google Scholar 

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792. https://doi.org/10.1056/NEJMoa050518

Article  CAS  PubMed  Google Scholar 

NIH, CDC (2022) State cancer profiles. https://statecancerprofiles.cancer.gov/index.html. Accessed 24 Jan 2022

Haynes B (1999) Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ 319(7211):652–653. https://doi.org/10.1136/bmj.319.7211.652

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif